Equillium Inc (EQ)’s stock has witnessed a price hike of 24.35% from the previous close with its current price standing at $0.49. Its current price is -67.59% under its 52-week high of $1.50 and 80.07% more than its 52-week low of $0.27.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, EQ’s SMA-200 is $0.6158.
Additionally, it is important to take into account EQ stock ratios, including its price-to-sales ratio, which is 0.57 for the last tewlve months.EQ’s price to book ratio for the most recent quarter was 1.64, resulting in an 1.20 price to cash per share for the period.
How does Equillium Inc (EQ) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Equillium Inc (EQ): Earnings History
If we examine Equillium Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$0.24, slashing the consensus of -$0.34. In other words, it beat the consensus by $0.1, resulting in a 28.36% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.24 in contrast with the Outlook of -$0.34. That was a difference of $0.1 and a surprise of 28.36%.
Equillium Inc (NASDAQ: EQ) Ownership Details
I will give a breakdown of the key shareholders in Equillium Inc (EQ). Recent figures show that the company’s insiders hold 35.90% of shares. A total of 27 institutional investors hold shares in the company, making 19.29% of its stock and 30.09% of its float.
Mar 31, 2025, it was reported that the Company’s largest institutional holder is Decheng Capital LLC holding total of 4.45 shares that make 12.45% of the company’s total number of shares and are currently priced at 2.17 million.
The securities firm Takeda Pharmaceutical Co Ltd. holds 1.82 shares of EQ, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 5.11%, and the holding percentage of shares is valued at 0.89 million.
An overview of Equillium Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Equillium Inc (EQ) traded 603,820 shares per day, with a moving average of $0.3858 and price change of +0.1241. With the moving average of $0.3665 and a price change of +0.0598, about 983,656 shares changed hands on average over the past 50 days. Finally, EQ’s 100-day average volume is 547,345 shares, alongside a moving average of $0.4415 and a price change of -0.3069.
